| AMP | Antimicrobial peptide |
| ATP | Adenosine triphosphate |
| AU | Arbitrary units (of bacteriocin activity) |
| BLIS | Bacteriocin-like inhibitory substance(s) |
| CFS | Cell-free supernatant |
| CFU | Colony-forming unit(s) |
| CHAP | Cysteine, histidine-dependent amidohydrolase/peptidase (endolysin catalytic domain) |
| CIP | Cleaning in place |
| CPS | Coagulase-positive staphylococci |
| DNA | Deoxyribonucleic acid |
| EHEC | Enterohemorrhagic Escherichia coli |
| EPS | Exopolysaccharide(s) |
| EU | European Union |
| GFP | Green fluorescent protein |
| GMO | Genetically modified organism |
| GRAS | Generally recognized as safe |
| HPP | High-pressure processing |
| HUS | Hemolytic uremic syndrome |
| ISAPP | International Scientific Association for Probiotics and Prebiotics |
| LAB | Lactic acid bacteria |
| MIC | Minimum inhibitory concentration |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| PFU | Plaque-forming unit(s) |
| RTE | Ready to eat |
| SE | Staphylococcal enterotoxin(s) |
| SEA–SEE | Staphylococcal enterotoxin types A to E |
| SFP | Staphylococcal food poisoning |
| STEC | Shiga toxin-producing Escherichia coli |
| Stx1/Stx2 | Shiga toxin 1/Shiga toxin 2 |
| VTEC | Verocytotoxin-producing Escherichia coli |